Umlaut.Bio

Pre-Seed
umlaut.bio Biotech & Healthcare Heidelberg, Germany
Total Funding Undisclosed
Latest Round Undisclosed Pre-Seed
Last Announced Feb 20, 2026
Investors Undisclosed
Decision Makers 1 Verified

About Umlaut.Bio

Umlaut.Bio is a spinout of the EMBL, is pursuing tRNA targets for treatment of cancer and immunological diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Pre-Seed
Global Headquarters Heidelberg, Germany
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website umlaut.bio
Domain Registered Date May 13, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Pre-Seed announced

  2. Milestone

    Website domain registered

    umlaut.bio

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Umlaut.Bio.

Funding History

1 Round
Pre-Seed equity · Feb 20, 2026
Undisclosed

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts